蛋白酶体抑制剂硼替佐米（万珂）在惰性非霍奇金淋巴瘤和套细胞淋巴瘤治疗中的显著疗效：美国血液学会第517-II号壁报展示

Promising activity of the proteasome inhibitor bortezomib (VELCADE) in the treatment of indolent non-Hodgkin's lymphoma and mantle cell lymphoma: ASH poster session 517-II.

作者信息

O'Connor Owen, Wright John, Moskowitz Craig H, Muzzy Jamie, MacGregor-Cortelli Barbara, Hamlin Paul, Straus David, Trehu Elizabeth, Schenkein David P, Zelenetz Andrew D

机构信息

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

出版信息

J Natl Compr Canc Netw. 2004 Nov;2 Suppl 4:S21-2.

PMID:19791425

Abstract

Dr. O'Connor delivered the following material as a poster at the 2003 American Society of Hematology meeting highlighting results from his work with bortezomib in the treatment of non-Hodgkin's and mantle cell lymphoma. A full publication of his results will appear later this year. Abstract #2346 appears in Blood, Volume 102, issue 11, November 16, 2003. The American Society of Hematology Poster Session "Lymphoma: Treatment and Supportive Care" took place on Sunday, December 7, 2003.

摘要

奥康纳博士在2003年美国血液学会会议上以海报形式展示了以下内容，重点介绍了他使用硼替佐米治疗非霍奇金淋巴瘤和套细胞淋巴瘤的研究成果。他的研究结果将在今年晚些时候全面发表。摘要#2346发表于《血液》杂志2003年11月16日第102卷第11期。美国血液学会海报展示会“淋巴瘤：治疗与支持性护理”于2003年12月7日星期日举行。